Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

NCT05148871 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Spikogen/Covax-19

Sponsor

Vaxine Pty Ltd

Collaborators

[object Object]
[object Object]